DISCOVERY HOUSE
Company number 13548751 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
DISCOVERY HOUSE - Analysis Report
Company Number: 13548751
Analysis Date: 2025-07-20 16:39 UTC
Financial Health Assessment for DISCOVERY HOUSE (Private Company Limited by Guarantee)
1. Financial Health Score: B-
Explanation:
DISCOVERY HOUSE shows a modest but positive financial position. The company has improved net current assets and net assets compared to previous years, indicating a return to a healthier state after initial losses. However, the balance sheet shows a tight working capital margin and reliance on amounts owed from related parties, which signals some underlying liquidity risks. The absence of fixed assets and reliance on grants and intercompany balances suggest a fragile financial structure typical of small non-trading or grant-dependent organizations.
2. Key Vital Signs
| Metric | 2024 Value (£) | Interpretation |
|---|---|---|
| Net Current Assets (Working Capital) | 20,800 | Positive working capital indicates the ability to meet short-term obligations, but margin is narrow. |
| Net Assets / Shareholders' Funds | 20,800 | Small but positive net worth reflects accumulated retained earnings and reserves. |
| Debtors (Receivables) | 380,028 | High level of receivables mainly from group undertakings; potential cash flow risk if not collected. |
| Creditors (Short-term liabilities) | 359,228 | Significant short-term liabilities owed predominantly to group undertakings; tight cash conversion. |
| Profit & Loss Account (Retained Earnings) | 20,800 | Accumulated surplus suggests some operational gains or funding inflows over time. |
| Turnover | Not disclosed | Turnover is not reported in detail; grants and rental income are the main revenue sources. |
| Audit Status | Exempt | Small entity exemption accepted; financials unaudited which may limit assurance. |
3. Diagnosis: Financial Condition Analysis
Liquidity & Working Capital: The company’s net current assets are positive but slim (£20.8k). This can be likened to a patient who has stable but borderline blood pressure — functioning but requiring monitoring. The large increase in debtors (£380k) almost equals creditors (£359k), primarily amounts owed to and from group undertakings, which means cash flow depends heavily on intercompany transactions. If these are delayed or disrupted, the company may face liquidity strain.
Capital Structure & Solvency: The company has a positive net asset position, recovering from a negative net asset base in 2021. This improvement signals that the company is gradually stabilizing. However, the absence of any fixed assets or investment property on the balance sheet (due to grant offsets) means it has limited tangible collateral, making it vulnerable if external funding support diminishes.
Profitability & Revenue Streams: The company does not report turnover details, but mentions rental and sundry income plus grants. The dependence on grant income and group undertakings suggests that the company’s operational health is dependent on external financial support rather than organic profitability. This is akin to a patient reliant on regular medication rather than natural health.
Governance & Management: The board is composed mainly of retired and non-executive directors, with several American nationals suggesting possible international involvement or oversight. No director remuneration is reported, which may indicate volunteer or non-salaried governance, common in non-profits or charitable entities.
Compliance & Reporting: The company filed accounts and confirmation statements on time with no overdue filings, indicating good compliance health and administrative discipline.
4. Recommendations: Steps to Improve Financial Wellness
Enhance Cash Flow Management:
- Prioritize timely collection of debtors, especially intercompany balances to avoid liquidity crunches.
- Consider formalising intercompany payment terms to ensure predictable cash inflows.
Diversify Revenue Sources:
- Reduce reliance on grants and group undertakings by exploring additional income streams, such as expanding rental income or service offerings.
- Develop a sustainable business model to improve organic revenue generation.
Strengthen Working Capital:
- Aim to build a buffer beyond the current slim net current assets to safeguard against unexpected liabilities or delays in receivables.
Asset and Funding Transparency:
- Clarify and document the status of grants offsetting fixed assets to improve transparency and stakeholder confidence.
Regular Financial Review:
- Conduct periodic financial health checks to monitor liquidity ratios and solvency.
- Consider voluntary audit or review to bolster assurance and credibility.
Governance Engagement:
- Ensure active engagement of directors in financial oversight despite their retired status.
- Possibly appoint a finance professional to strengthen financial governance and strategic planning.
Medical Analogy Summary
DISCOVERY HOUSE’s financial health resembles a recovering patient with a stable but fragile condition. The company’s balance sheet shows signs of healing—positive net assets and working capital—but its “circulatory system” (cash flow) is heavily dependent on timely support from related entities. Without diversification and improved cash flow management, it risks relapse into distress. Strengthening its financial “immune system” through broader income sources and tighter liquidity control will enhance its resilience and sustainability.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.